Show simple item record

Gender influences adhesion to recommendations for optimal comorbidity screening and management of patients with chronic inflammatory rheumatic diseases starting a biological disease-modifying antirheumatic drug

dc.contributor.authorAthan Baillet
dc.contributor.authorRomain Gastaldi
dc.contributor.authorAlexandre Lagadou
dc.contributor.authorLauriane Vacher
dc.contributor.otherUMR5525, La Tronche, France
dc.contributor.otherCHU Grenoble Alpes, Grenoble, France
dc.contributor.otherCHU Grenoble Alpes, Grenoble, France
dc.contributor.otherUMR5525, La Tronche, France
dc.date.accessioned2025-10-09T04:55:15Z
dc.date.available2025-10-09T04:55:15Z
dc.date.issued01-November-2024
dc.identifier.urihttps://rmdopen.bmj.com/content/10/4/e004364.full
dc.identifier.urihttp://digilib.fisipol.ugm.ac.id/repo/handle/15717717/40840
dc.language.isoEN
dc.publisherBMJ Publishing Group
dc.subject.lccMedicine
dc.titleGender influences adhesion to recommendations for optimal comorbidity screening and management of patients with chronic inflammatory rheumatic diseases starting a biological disease-modifying antirheumatic drug
dc.typeArticle
dc.description.doi10.1136/rmdopen-2024-004364
dc.title.journalRMD Open
dc.identifier.e-issn2056-5933
dc.identifier.oaioai:doaj.org/journal:9f1979ff509049549d6511949850ee22
dc.journal.infoVolume 10, Issue 4


This item appears in the following Collection(s)

Show simple item record